TY - JOUR T1 - Association Between Reduced Handgrip Strength and Commonly Prescribed Medications JF - medRxiv DO - 10.1101/2020.01.15.20017087 SP - 2020.01.15.20017087 AU - Bryan L. Love AU - Erin M. Mitchell AU - LeAnn B. Norris Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/01/16/2020.01.15.20017087.abstract N2 - Decreased handgrip-strength has become an increasingly important measure of overall health status and fitness. This was a cross-sectional analysis among adult participants in the 2011-2012 NHANES survey. Handgrip-strength was assessed using a digital dynamometer and a standard protocol, and medication use was assessed by self-report and verification by the interviewer. Mean handgrip-strength among participants with no medication use was 87.2kg in males and 57.2kg in females. Handgrip strength decreased significantly in both men and women (ptrend<0.001 for both) with increasing medication use after adjustment for age, sex, height, arm circumference, and BMI. Statins, ACE-inhibitors, ARBs, diuretics, calcium channel blockers, and sulfonylureas showed a consistent and significant decrease in grip strength in linear regression models. In this nationally representative survey of adults in the US, we observed a negative relationship between handgrip strength and polypharmacy. Further, several specific medications, mostly cardiovascular drug classes, were associated with reduced handgrip-strength.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo financial relationships with any commercial entity exist or have influenced the writing of this manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data utilized in the analysis is freely available at the NHANES website. https://wwwn.cdc.gov/nchs/nhanes/default.aspx ER -